Gewinn- und Verlustrechnung von Ginkgo Bioworks Holdings, Inc.

- Strengthened balance sheet with $1.8 million cash from new convertible debt in Q2 and additional $5.0 million through the sale of preferred stock after quarter end

Prada Group CEO Andrea Guerra speaks to CNBC's Charlotte Reed about global luxury consumers, keeping the brand innovative and relevant, AI in fashion, and why they wanted to design the next generation of astronauts' spacesuits. Subscribe: @CNBCInternationalLive Subscribe to CNBC International: @CNBCInternational LinkedIn: https://www.linkedin.com/showcase/cnbc-international/ TikTok: https://www.tiktok.com/@cnbci Facebook: https://www.facebook.com/cnbcinternational Instagram: https://www.instagram.com/cnbcinternational/ Threads: https://www.threads.net/@cnbcinternational X: https://twitter.com/CNBCi Telegram: https://t.me/cnbci

Ginkgo Bioworks NYSE: DNA reported second-quarter 2026 revenue of $20 million, down 48% from the year-earlier period, as the company continued to shift its focus toward autonomous laboratory systems, contract research services and related software.

Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2026 Earnings Call Transcript

NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV), a global leader in payments and financial technology, today announced that UW Credit Union, one of the nation's leading credit unions, has selected DNA® from Fiserv as its future core processing platform. The decision expands UW Credit Union's relationship with Fiserv and provides a modern foundation to support growth, operational efficiency and enhanced member experience.

DNA Advisors brings expertise in capital markets, strategic transactions, partnerships, and growth initiatives DNA Advisors brings expertise in capital markets, strategic transactions, partnerships, and growth initiatives

CoreWeave (NASDAQ: CRWV) and Nebius Group (NASDAQ: NBIS | NBIS Price Prediction) just delivered Q1 2026 results that look similar on the surface: both are NVIDIA-backed AI cloud providers chasing hyperscaler contracts.

Caxton Associates LLP lowered its stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) by 60.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,778 shares of the company's stock after selling 103,802 shares during the quarter. Caxton Associates LLP owned

Gene-editing is a handy tool for developing sophisticated medicines. A new CRISPR molecule can destroy cells that express specific signals.

SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the n.